Bordetella pertussis, Finland and France

被引：28
作者：
Caro, Valerie
Elomaa, Annika
Brun, Delphine
Mertsola, Jussi
He, Qiushui
Guiso, Nicole
机构：
[1] Inst Pasteur, FRE 2849, CNRS, F-75724 Paris, France
[2] Turku Univ, Dept Med Microbiol, FIN-20520 Turku, Finland
[3] Natl Publ Hlth Inst, Turku, Finland
来源：
EMERGING INFECTIOUS DISEASES | 2006年 / 12卷 / 06期
关键词：
D O I：
10.3201/eid1206.051283
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We used pulsed-field gel electrophoresis analysis and genotyping to compare clinical isolates of Bordetella pertussis recovered since the early 1990s in Finland and France, 2 countries with similar histories of long-term mass vaccination with whole-cell pertussis vaccines. Isolates from both countries were similar genetically but varied temporally.
引用
收藏
页码：987 / 989
页数：3
相关论文
共 15 条
[1]   Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies [J].
Caro, V ;
Njamkepo, E ;
Van Amersfoorth, SCM ;
Mooi, FR ;
Advani, A ;
Hallander, HO ;
He, QS ;
Mertsola, J ;
Riffelmann, M ;
Vahrenholz, C ;
Von König, CHW ;
Guiso, N .
MICROBES AND INFECTION, 2005, 7 (7-8) :976-982
[2]   Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years [J].
Elomaa, A ;
Advani, A ;
Donnelly, D ;
Antila, M ;
Mertsola, J ;
Hallander, H ;
He, QS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) :3681-3687
[3]  
Forsyth Kevin, 2005, Pediatr Infect Dis J, V24, pS69, DOI 10.1097/01.inf.0000160917.29723.03
[4]   Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom [J].
Fry, NK ;
Neal, S ;
Harrison, TG ;
Miller, E ;
Matthews, R ;
George, RC .
INFECTION AND IMMUNITY, 2001, 69 (09) :5520-5528
[5]   Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland [J].
Gzyl, A ;
Augustynowicz, E ;
van Loo, I ;
Slusarczyk, J .
VACCINE, 2001, 20 (3-4) :299-303
[6]  
Hardwick TH, 2002, EMERG INFECT DIS, V8, P44
[7]   Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children [J].
Mastrantonio, P ;
Spigaglia, P ;
van Oirschot, H ;
van der Heide, HGJ ;
Heuvelman, K ;
Stefanelli, P ;
Mooi, FR .
MICROBIOLOGY-UK, 1999, 145 :2069-2075
[8]   Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies [J].
Mattoo, S ;
Cherry, JD .
CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (02) :326-+
[9]   Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands:: Temporal trends and evidence for vaccine-driven evolution [J].
Mooi, FR ;
van Oirschot, H ;
Heuvelman, K ;
van der Heide, HGJ ;
Gaastra, W ;
Willems, RJL .
INFECTION AND IMMUNITY, 1998, 66 (02) :670-675
[10]   Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity [J].
Njamkepo, E ;
Rimlinger, F ;
Thiberge, S ;
Guiso, N .
VACCINE, 2002, 20 (9-10) :1290-1294
12